1. Home
  2. ETON vs FEAM Comparison

ETON vs FEAM Comparison

Compare ETON & FEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETON
  • FEAM
  • Stock Information
  • Founded
  • ETON 2017
  • FEAM 2016
  • Country
  • ETON United States
  • FEAM United States
  • Employees
  • ETON N/A
  • FEAM N/A
  • Industry
  • ETON Biotechnology: Pharmaceutical Preparations
  • FEAM Major Chemicals
  • Sector
  • ETON Health Care
  • FEAM Industrials
  • Exchange
  • ETON Nasdaq
  • FEAM Nasdaq
  • Market Cap
  • ETON 199.5M
  • FEAM 44.6M
  • IPO Year
  • ETON 2018
  • FEAM N/A
  • Fundamental
  • Price
  • ETON $8.82
  • FEAM $0.47
  • Analyst Decision
  • ETON Strong Buy
  • FEAM Buy
  • Analyst Count
  • ETON 3
  • FEAM 4
  • Target Price
  • ETON $12.00
  • FEAM $4.19
  • AVG Volume (30 Days)
  • ETON 214.1K
  • FEAM 153.2K
  • Earning Date
  • ETON 11-11-2024
  • FEAM 11-11-2024
  • Dividend Yield
  • ETON N/A
  • FEAM N/A
  • EPS Growth
  • ETON N/A
  • FEAM N/A
  • EPS
  • ETON N/A
  • FEAM N/A
  • Revenue
  • ETON $31,381,000.00
  • FEAM N/A
  • Revenue This Year
  • ETON $19.61
  • FEAM N/A
  • Revenue Next Year
  • ETON $35.39
  • FEAM $1,117.19
  • P/E Ratio
  • ETON N/A
  • FEAM N/A
  • Revenue Growth
  • ETON 8.14
  • FEAM N/A
  • 52 Week Low
  • ETON $3.03
  • FEAM $0.40
  • 52 Week High
  • ETON $8.66
  • FEAM $2.61
  • Technical
  • Relative Strength Index (RSI)
  • ETON 76.07
  • FEAM 38.57
  • Support Level
  • ETON $7.58
  • FEAM $0.43
  • Resistance Level
  • ETON $8.66
  • FEAM $0.57
  • Average True Range (ATR)
  • ETON 0.42
  • FEAM 0.06
  • MACD
  • ETON -0.07
  • FEAM -0.01
  • Stochastic Oscillator
  • ETON 91.49
  • FEAM 26.20

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.

About FEAM 5E Advanced Materials Inc.

5E Advanced Materials Inc is an exploration stage company focused on becoming a vertically integrated supplier of specialty boron and boron derivative materials whose mission is to enable decarbonization, increase food security, and ensure domestic supply of critical materials. It has a project located in southern California underpinned by a mineral resource that includes boron and lithium, with the boron being contained in a conventional boron mineral known as colemanite. The company seeks to extract and process the minerals into boric acid, boron materials, lithium carbonate, and potentially other co-products on a commercial scale.

Share on Social Networks: